Dr. Reddy's Laboratories receives NCLT approval for scheme of amalgamation

Image
Capital Market
Last Updated : Apr 07 2022 | 7:31 PM IST
Dr. Reddy's Laboratories has received the approval of the National Company Law Tribunal (NCLT), Hyderabad Bench for the scheme of amalgamation of Dr Reddy's Holdings an entity held by the Promoter Group, which holds 24.83% equity shares of Dr. Reddy's Laboratories into the Company. The scheme was approved on 05 April 2022 and the order was uploaded on the NCLT website on 07 April 2022.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 07 2022 | 7:21 PM IST

Next Story